See also this year's filing and all EDGAR filings for this company.
PDF Report 0001434868_2024_Esperion_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001434868, Esperion Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 201,065,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 4,731,000 |
| 4 | LiabilitiesCurrent | 156,224,000 |
| 5 | LiabilitiesNoncurrent | 3,020,000 |
| 6 | remainder_Liabilities | 501,546,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 144,576,005 |
| 9 | ResearchAndDevelopmentExpense | 63,065,375 |
| 10 | remainder_Expenses | 172,429,917 |
| 11 | remainder_Revenues | 116,548,151 |
| 12 | remainder_NetIncome | 3,832,480 |
| 13 | remainder_ComprehensiveNetIncome | 15,187 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 205,796,000 |
| 1 | Liabilities | 660,790,000 |
| 2 | Expenses | 380,071,297 |
| 3 | Revenues | 116,548,151 |
| 4 | StockholdersEquity | -454,994,000 |
| 5 | NetIncome | -259,690,666 |
| 6 | ComprehensiveNetIncome | -259,683,072 |
| 7 | BaseVar | 683,526,558 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -2.89 |
| 9 | EconomicCapitalRatio | 0.724 |